Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00186628
Status:
COMPLETED
Last Update Posted:
2017-11-28
First Post:
2005-09-14
Brief Title:
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Sponsor:
Stanford University
Organization:
Stanford University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-14
First Submit QC Date:
September 14 2005
Study First Post Date:
2005-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-11-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-20
Last Update Post Date:
2017-11-28
Last Update Post Date Type:
ACTUAL